DENVER, Colo., Oct 12, 2023 (www.247marketnews.com)- Jaguar Health, Inc. (NASDAQ: JAGX) stated, this morning, that the company’s founder, president and CEO, will present and host one-on-one meetings with investors on October 17 and 18, 2023, and on October 18, 2023, with top line results expected in the coming weeks for company’s phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea
Jaguar Health is trading at $0.47, up $0.228 (+94.21%), on 44.7M premarket shares traded.
Its 52-week range is $0.2249 to $12.90. It basically spent the past week trading at its 52-week low and is trying to reverse that trend.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
